![MMI - Marcus & Millichap Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=MMI&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 1.54B | EPS (ttm) | -0.99 |
P/E | - | EPS this Y | 40.91% |
Forward P/E | 46.36 | EPS next Y | 265.38% |
PEG | - | EPS past 5Y | - |
P/S | 2.49 | EPS next 5Y | 6.00% |
P/B | 2.46 | EPS Q/Q | -74.85% |
Dividend | 1.25% | Sales Q/Q | -16.60% |
Insider Own | 37.65% | Inst Own | 62.01% |
Insider Trans | -0.30% | Inst Trans | -0.25% |
Short Float | 2.93% | Earnings | Aug 07/b |
Analyst Recom | 5.00 | Target Price | 20.00 |
Avg Volume | 116.74K | 52W Range | 26.81 - 44.24 |
|
|
|
Marcus & Millichap, Inc. engages in the provision of investment real estate brokerage services. It specializes in commercial real estate investment sales, property financing, research, and advisory services. The company was founded by George M. Marcus and William A. Millichap in 1971 and is headquartered in Calabasas, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Nadji Hessam | Chief Executive Officer | Jul 26 '24 | Sale | 40.05 | 300 | 12,016 | 223,023 | Jul 26 08:49 PM | Nadji Hessam | Chief Executive Officer | Jul 25 '24 | Sale | 40.03 | 800 | 32,026 | 223,323 | Jul 26 08:49 PM | Nadji Hessam | Chief Executive Officer | Jul 12 '24 | Sale | 35.27 | 15,000 | 529,038 | 224,123 | Jul 15 07:44 PM | LaBerge Gregory A. | Chief Administrative Officer | May 28 '24 | Sale | 32.68 | 1,000 | 32,677 | 6,050 | May 29 08:38 PM | Matricaria Richard D. | EVP & COO - Western Division | May 17 '24 | Sale | 35.30 | 1,848 | 65,234 | 7,695 | May 21 04:41 PM |
|
|
![](gfx/nic2x2.gif) |
![CLSK - Cleanspark Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=CLSK&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 3.90B | EPS (ttm) | 0.13 |
P/E | 128.72 | EPS this Y | 286.82% |
Forward P/E | 174.50 | EPS next Y | -84.74% |
PEG | - | EPS past 5Y | 37.20% |
P/S | 13.75 | EPS next 5Y | - |
P/B | 2.64 | EPS Q/Q | 354.62% |
Dividend | - | Sales Q/Q | 162.77% |
Insider Own | 3.30% | Inst Own | 44.15% |
Insider Trans | -13.50% | Inst Trans | 4.32% |
Short Float | 16.68% | Earnings | May 09/b |
Analyst Recom | 1.50 | Target Price | 24.25 |
Avg Volume | 30.43M | 52W Range | 3.38 - 24.72 |
|
|
|
CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Monnig Taylor | Chief Technology Officer | Jul 26 '24 | Sale | 16.97 | 1,350 | 22,910 | 212,352 | Jul 26 07:56 PM | Monnig Taylor | Chief Technology Officer | Jun 28 '24 | Sale | 16.03 | 1,350 | 21,640 | 213,702 | Jun 28 08:58 PM | Monnig Taylor | Chief Technology Officer | May 31 '24 | Sale | 16.65 | 1,350 | 22,477 | 215,052 | May 31 07:17 PM | Schultz S. Matthew | Executive Chairman | Mar 27 '24 | Sale | 23.07 | 367,000 | 8,466,690 | 2,298,975 | Mar 27 05:20 PM | Bradford Zachary | CEO and President | Mar 21 '24 | Sale | 20.31 | 443,000 | 8,997,330 | 2,795,863 | Mar 21 09:40 PM |
|
|
![](gfx/nic2x2.gif) |
![OPK - Opko Health Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=OPK&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 1.03B | EPS (ttm) | -0.34 |
P/E | - | EPS this Y | -53.33% |
Forward P/E | - | EPS next Y | 25.65% |
PEG | - | EPS past 5Y | 1.56% |
P/S | 1.29 | EPS next 5Y | 12.00% |
P/B | 0.82 | EPS Q/Q | -376.54% |
Dividend | - | Sales Q/Q | -26.89% |
Insider Own | 53.01% | Inst Own | 25.68% |
Insider Trans | 1.48% | Inst Trans | -3.05% |
Short Float | 25.52% | Earnings | May 07/a |
Analyst Recom | 1.00 | Target Price | 3.83 |
Avg Volume | 3.59M | 52W Range | 0.85 - 2.17 |
|
|
|
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
OPKO HEALTH, INC. | 10% Owner | Jul 26 '24 | Sale | 33.85 | 60,000 | 2,031,258 | 3,123,403 | Jul 26 07:49 PM | OPKO HEALTH, INC. | 10% Owner | Jul 24 '24 | Sale | 33.72 | 75,000 | 2,529,105 | 3,183,403 | Jul 26 07:49 PM | OPKO HEALTH, INC. | 10% Owner | Jul 23 '24 | Sale | 33.46 | 75,000 | 2,509,245 | 3,258,403 | Jul 23 05:16 PM | OPKO HEALTH, INC. | 10% Owner | Jul 22 '24 | Sale | 32.61 | 50,000 | 1,630,440 | 3,333,403 | Jul 23 05:16 PM | OPKO HEALTH, INC. | 10% Owner | Jul 19 '24 | Sale | 32.29 | 25,000 | 807,250 | 3,383,403 | Jul 23 05:16 PM |
|
|
| ![](gfx/nic2x2.gif) |
![WGS - GeneDx Holdings Corp - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=WGS&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 876.81M | EPS (ttm) | -5.25 |
P/E | - | EPS this Y | 73.48% |
Forward P/E | - | EPS next Y | 79.31% |
PEG | - | EPS past 5Y | - |
P/S | 3.95 | EPS next 5Y | - |
P/B | 4.23 | EPS Q/Q | 74.45% |
Dividend | - | Sales Q/Q | 44.70% |
Insider Own | 37.04% | Inst Own | 55.24% |
Insider Trans | -0.45% | Inst Trans | -11.87% |
Short Float | 9.80% | Earnings | Jul 30/a |
Analyst Recom | 1.80 | Target Price | 34.60 |
Avg Volume | 583.00K | 52W Range | 1.16 - 35.65 |
|
|
Jul-12-24 12:00PM
|
All You Need to Know About GENEDX HOLDINGS (WGS) Rating Upgrade to Strong Buy
(Zacks) |
Jul-11-24 04:05PM
|
GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
(GlobeNewswire) +9.36% |
Jul-06-24 07:00AM
|
7 Small-Cap Stocks With Massive Potential Returns
(InvestorPlace) |
Jun-10-24 08:30AM
|
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
(GlobeNewswire) |
Jun-05-24 07:00AM
|
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
(GlobeNewswire) +13.20% |
May-22-24 04:05PM
|
GeneDx to Participate in Upcoming Investor Conferences
(GlobeNewswire) |
May-16-24 02:20PM
|
Hedge Fund and Insider Trading News: Michael Burry, Leon Cooperman, Ray Dalio, Stanley Druckenmiller, Millennium Management, Paulson & Co, Rokos Capital Management, Humacyte Inc (HUMA), GeneDx Holdings Corp. (WGS), and More
(Insider Monkey) +13.52% |
Apr-30-24 07:31AM
|
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
(InvestorPlace) +55.18% |
Apr-29-24 08:55PM
|
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024
(InvestorPlace) |
05:50PM
|
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Tops Revenue Estimates
(Zacks) |
|
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
OPKO HEALTH, INC. | 10% Owner | Jul 26 '24 | Sale | 33.85 | 60,000 | 2,031,258 | 3,123,403 | Jul 26 07:49 PM | OPKO HEALTH, INC. | 10% Owner | Jul 24 '24 | Sale | 33.72 | 75,000 | 2,529,105 | 3,183,403 | Jul 26 07:49 PM | OPKO HEALTH, INC. | 10% Owner | Jul 23 '24 | Sale | 33.46 | 75,000 | 2,509,245 | 3,258,403 | Jul 23 05:16 PM | OPKO HEALTH, INC. | 10% Owner | Jul 22 '24 | Sale | 32.61 | 50,000 | 1,630,440 | 3,333,403 | Jul 23 05:16 PM | OPKO HEALTH, INC. | 10% Owner | Jul 19 '24 | Sale | 32.29 | 25,000 | 807,250 | 3,383,403 | Jul 23 05:16 PM |
|
|
![](gfx/nic2x2.gif) |
![REXR - Rexford Industrial Realty Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=REXR&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 10.77B | EPS (ttm) | 1.21 |
P/E | 40.61 | EPS this Y | 6.03% |
Forward P/E | 36.24 | EPS next Y | 13.95% |
PEG | 4.06 | EPS past 5Y | 22.03% |
P/S | 12.45 | EPS next 5Y | 10.00% |
P/B | 1.36 | EPS Q/Q | 42.82% |
Dividend | 3.38% | Sales Q/Q | 21.03% |
Insider Own | 0.21% | Inst Own | 123.71% |
Insider Trans | -9.52% | Inst Trans | 1.05% |
Short Float | 2.42% | Earnings | Jul 17/a |
Analyst Recom | 2.06 | Target Price | 54.59 |
Avg Volume | 1.52M | 52W Range | 41.56 - 58.02 |
|
|
|
Rexford Industrial Realty, Inc. is a self-administered and self-managed real estate investment trust, which engages in owning and operating industrial properties in infill markets. The company was founded by Richard S. Ziman on January 18, 2013 and is headquartered in Los Angeles, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Schwimmer Howard | Co-CEO, Co-President | Jul 26 '24 | Sale | 48.86 | 30,358 | 1,483,343 | 50,673 | Jul 26 07:12 PM | Lanzer David E. | General Counsel & Secretary | Feb 12 '24 | Sale | 52.69 | 18,113 | 954,408 | 0 | Feb 13 08:34 PM | CLARK LAURA E | Chief Financial Officer | Jul 28 '23 | Sale | 54.48 | 7,410 | 403,703 | 2,562 | Jul 28 09:02 PM |
|
|
| ![](gfx/nic2x2.gif) |
![MRNA - Moderna Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=MRNA&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 46.80B | EPS (ttm) | -15.68 |
P/E | - | EPS this Y | 42.84% |
Forward P/E | - | EPS next Y | 24.49% |
PEG | - | EPS past 5Y | -20.02% |
P/S | 9.10 | EPS next 5Y | - |
P/B | 3.65 | EPS Q/Q | -1676.58% |
Dividend | - | Sales Q/Q | -91.07% |
Insider Own | 12.13% | Inst Own | 66.80% |
Insider Trans | -1.35% | Inst Trans | 0.89% |
Short Float | 6.75% | Earnings | Aug 01/b |
Analyst Recom | 2.44 | Target Price | 144.32 |
Avg Volume | 3.94M | 52W Range | 62.55 - 170.47 |
|
|
|
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
AFEYAN NOUBAR | Director | Jul 24 '24 | Sale | 117.80 | 15,000 | 1,766,972 | 2,239,015 | Jul 26 07:00 PM | AFEYAN NOUBAR | Director | Jul 17 '24 | Sale | 122.84 | 15,000 | 1,842,651 | 2,254,015 | Jul 19 07:00 PM | Hoge Stephen | President | Jul 15 '24 | Sale | 121.12 | 15,000 | 1,816,800 | 1,442,089 | Jul 16 04:08 PM | AFEYAN NOUBAR | Director | Jul 10 '24 | Sale | 117.08 | 15,000 | 1,756,177 | 2,269,015 | Jul 12 07:00 PM | Mock James M | Chief Financial Officer | Jul 08 '24 | Sale | 118.24 | 689 | 81,465 | 7,269 | Jul 09 04:34 PM |
|
|
![](gfx/nic2x2.gif) |
![ZM - Zoom Video Communications Inc - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=ZM&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 18.58B | EPS (ttm) | 2.69 |
P/E | 22.35 | EPS this Y | -3.15% |
Forward P/E | 11.76 | EPS next Y | 1.28% |
PEG | 14.90 | EPS past 5Y | - |
P/S | 4.07 | EPS next 5Y | 1.50% |
P/B | 2.24 | EPS Q/Q | 1250.20% |
Dividend | - | Sales Q/Q | 3.25% |
Insider Own | 22.26% | Inst Own | 59.49% |
Insider Trans | -0.41% | Inst Trans | -0.53% |
Short Float | 3.71% | Earnings | May 20/a |
Analyst Recom | 2.57 | Target Price | 74.61 |
Avg Volume | 3.21M | 52W Range | 55.63 - 75.90 |
|
|
|
Zoom Video Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Steckelberg Kelly | Chief Financial Officer | Jul 24 '24 | Sale | 58.64 | 5,007 | 293,612 | 0 | Jul 26 06:39 PM | Bawa Aparna | Chief Operating Officer | Jul 18 '24 | Sale | 56.81 | 10,332 | 586,964 | 1,978 | Jul 19 07:10 PM | Yuan Eric S. | Chief Executive Officer | Jul 10 '24 | Sale | 56.20 | 20,910 | 1,175,141 | 92,774 | Jul 10 08:52 PM | Sankarlingam Velchamy | Pres. of Engineering & Product | Jul 10 '24 | Sale | 56.70 | 12,959 | 734,775 | 80,500 | Jul 10 09:20 PM | Steckelberg Kelly | Chief Financial Officer | Jul 10 '24 | Sale | 56.23 | 5,007 | 281,530 | 0 | Jul 10 08:50 PM |
|
|
| ![](gfx/nic2x2.gif) |
![DGX - Quest Diagnostics, Inc. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=DGX&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 16.21B | EPS (ttm) | 7.41 |
P/E | 19.64 | EPS this Y | 2.17% |
Forward P/E | 15.19 | EPS next Y | 7.68% |
PEG | 3.91 | EPS past 5Y | 7.36% |
P/S | 1.73 | EPS next 5Y | 5.03% |
P/B | 2.44 | EPS Q/Q | -0.82% |
Dividend | 2.00% | Sales Q/Q | 2.52% |
Insider Own | 0.49% | Inst Own | 94.06% |
Insider Trans | -3.29% | Inst Trans | -1.34% |
Short Float | 2.06% | Earnings | Jul 23/b |
Analyst Recom | 2.26 | Target Price | 151.86 |
Avg Volume | 897.22K | 52W Range | 119.59 - 150.59 |
|
|
|
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DELANEY MARK E | SVP & Chief Commercial Officer | Jul 24 '24 | Sale | 143.08 | 420 | 60,094 | 5,019 | Jul 26 06:33 PM | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Apr 29 '24 | Sale | 140.00 | 1,760 | 246,400 | 13,435 | May 01 04:26 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 29 '24 | Sale | 125.88 | 5,611 | 706,313 | 38,478 | Mar 01 04:50 PM | Doherty Catherine T. | EVP, Regional Businesses | Feb 29 '24 | Sale | 125.88 | 1,187 | 149,420 | 68,412 | Mar 01 04:51 PM | Doherty Catherine T. | EVP, Regional Businesses | Feb 28 '24 | Sale | 126.57 | 5,557 | 703,349 | 69,599 | Mar 01 04:51 PM |
|
|
![](gfx/nic2x2.gif) |
![HEI-A - Heico Corp. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=HEI-A&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 25.61B | EPS (ttm) | 3.17 |
P/E | 58.24 | EPS this Y | 20.34% |
Forward P/E | 43.79 | EPS next Y | 20.58% |
PEG | - | EPS past 5Y | 8.91% |
P/S | 7.29 | EPS next 5Y | - |
P/B | 7.55 | EPS Q/Q | 15.93% |
Dividend | 0.12% | Sales Q/Q | 38.90% |
Insider Own | 45.20% | Inst Own | 56.17% |
Insider Trans | -0.20% | Inst Trans | - |
Short Float | 0.53% | Earnings | May 29/b |
Analyst Recom | 1.86 | Target Price | 240.97 |
Avg Volume | 261.18K | 52W Range | 124.32 - 185.70 |
|
|
|
HEICO Corp. engages in the manufacturing of electronic equipment for the aviation, defense, space, medical, telecommunications, and electronics industries. It operates through the Flight Support Group and Electronic Technologies Group segments. The Flight Support Group segment designs, manufactures, repairs, overhauls, and distributes jet engine and aircraft component replacement parts. The Electronic Technologies Group segment focuses on designing and manufacturing electronic, data and microwave, and electro-optical products, including infrared simulation and test equipment, laser rangefinder receivers, electrical power supplies, back-up power supplies, power conversion products, underwater locator beacons, emergency locator transmission beacons, flight deck annunciators, panels and indicators, electromagnetic and radio frequency interference shielding and filters, high power capacitor charging power supplies, amplifiers, traveling wave tube amplifiers, photo detectors, amplifier modules, microwave power modules, flash lamp drivers, laser diode drivers, arc lamp power supplies, custom power supply designs, cable assemblies, high voltage power supplies, high voltage interconnection devices and wire, high voltage energy generators, high frequency power delivery systems, and memory products. The company was founded in 1957 and is headquartered in Hollywood, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MENDELSON ERIC A | Co-President | Jul 26 '24 | Sale | 186.09 | 20,000 | 3,721,740 | 148,891 | Jul 26 06:27 PM | MENDELSON ERIC A | Co-President | Jul 16 '24 | Sale | 182.02 | 53,510 | 9,739,821 | 168,891 | Jul 17 01:53 PM | MENDELSON ERIC A | Co-President | Jul 08 '24 | Sale | 180.54 | 8,864 | 1,600,294 | 222,401 | Jul 09 04:37 PM | MENDELSON ERIC A | Co-President | Jun 25 '24 | Sale | 180.56 | 14,795 | 2,671,338 | 231,265 | Jun 26 03:36 PM | MENDELSON ERIC A | Co-President | Jun 24 '24 | Sale | 180.06 | 2,832 | 509,939 | 246,060 | Jun 26 03:36 PM |
|
|
![](gfx/nic2x2.gif) |
![HEI - Heico Corp. - Stock Price Chart](https://charts2-node.finviz.com/chart.ashx?cs=l&t=HEI&tf=d&s=linear&ct=candle_stick&tm=d&o[0][ot]=sma&o[0][op]=50&o[0][oc]=FF8F33C6&o[1][ot]=sma&o[1][op]=200&o[1][oc]=DCB3326D&o[2][ot]=sma&o[2][op]=20&o[2][oc]=DC32B363&o[3][ot]=patterns&o[3][op]=&o[3][oc]=000) |
Market Cap | 32.44B | EPS (ttm) | 3.17 |
P/E | 73.78 | EPS this Y | 20.34% |
Forward P/E | 55.47 | EPS next Y | 20.58% |
PEG | 4.17 | EPS past 5Y | 8.91% |
P/S | 9.24 | EPS next 5Y | 17.68% |
P/B | 9.57 | EPS Q/Q | 15.93% |
Dividend | 0.10% | Sales Q/Q | 38.90% |
Insider Own | 69.50% | Inst Own | 29.97% |
Insider Trans | -0.13% | Inst Trans | -0.00% |
Short Float | 3.93% | Earnings | May 29/b |
Analyst Recom | 1.86 | Target Price | 240.97 |
Avg Volume | 397.67K | 52W Range | 155.42 - 233.99 |
|
|
|
HEICO Corp. engages in the manufacturing of electronic equipment for the aviation, defense, space, medical, telecommunications, and electronics industries. It operates through the Flight Support Group and Electronic Technologies Group segments. The Flight Support Group segment designs, manufactures, repairs, overhauls, and distributes jet engine and aircraft component replacement parts. The Electronic Technologies Group segment focuses on designing and manufacturing electronic, data and microwave, and electro-optical products, including infrared simulation and test equipment, laser rangefinder receivers, electrical power supplies, back-up power supplies, power conversion products, underwater locator beacons, emergency locator transmission beacons, flight deck annunciators, panels and indicators, electromagnetic and radio frequency interference shielding and filters, high power capacitor charging power supplies, amplifiers, traveling wave tube amplifiers, photo detectors, amplifier modules, microwave power modules, flash lamp drivers, laser diode drivers, arc lamp power supplies, custom power supply designs, cable assemblies, high voltage power supplies, high voltage interconnection devices and wire, high voltage energy generators, high frequency power delivery systems, and memory products. The company was founded in 1957 and is headquartered in Hollywood, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MENDELSON ERIC A | Co-President | Jul 26 '24 | Sale | 186.09 | 20,000 | 3,721,740 | 148,891 | Jul 26 06:27 PM | MENDELSON ERIC A | Co-President | Jul 16 '24 | Sale | 182.02 | 53,510 | 9,739,821 | 168,891 | Jul 17 01:53 PM | MENDELSON ERIC A | Co-President | Jul 08 '24 | Sale | 180.54 | 8,864 | 1,600,294 | 222,401 | Jul 09 04:37 PM | MENDELSON ERIC A | Co-President | Jun 25 '24 | Sale | 180.56 | 14,795 | 2,671,338 | 231,265 | Jun 26 03:36 PM | MENDELSON ERIC A | Co-President | Jun 24 '24 | Sale | 180.06 | 2,832 | 509,939 | 246,060 | Jun 26 03:36 PM |
|
|
|